The matrix metalloproteinases and CNS plasticity: An overview

Journal of Neuroimmunology

Volumn 187, Issue 1-2, 2007, Pages 9-19

  Milward, E A ^a   Fitzsimmons, C ^a   Szklarczyk, A ^b   Conant, K ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CNS plasticity; Cognition; Development; Injury; Matrix metalloproteinases; TIMPs

Indexed keywords

CYTOKINE; GROWTH FACTOR; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

BRAIN FUNCTION; CELL DEATH; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; COGNITION; EXTRACELLULAR MATRIX; HUMAN; LEARNING; MEMORY; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INJURY; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MATRIX METALLOPROTEINASES; NEURONAL PLASTICITY;

EID: 34347256340     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.04.010     Document Type: Review

References (119)

1. Alimenti E., Tafuri S., Scibelli A., D'Angelo D., Manna L., Pavone L.M., Belisario M.A., and Staiano N. Pro-apoptotic signaling pathway activated by echistatin in GD25 cells. Biochim. Biophys. Acta 1693 (2004) 73-80
2. Anderson M.J., Shi Z.Q., and Zackson S.L. Proteolytic disruption of laminin-integrin complexes on muscle cells during synapse formation. Mol. Cell. Biol. 16 (1996) 4972-4984
3. Apodaca G., Rutka J.T., Bouhana K., Berens M.E., Giblin J.R., Rosenblum M.L., McKerrow J.H., and Banda M.J. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and gliomal cells. Cancer Res. 50 (1990) 2322-2329
4. Backstrom J.R., Lim G.P., Cullen M.J., and Tokes Z.A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J. Neurosci. 16 (1996) 7910-7919
5. Baker A.H., Edwards D.R., and Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115 (2002) 3719-3727
6. Ben-Hur T., Ben-Yosef Y., Mizrachi-Kol R., Ben-Menachem O., and Miller A. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells. J. Neuroimmunol. 175 (2006) 12-18
7. Bernard-Trifilo J.A., Kramer E.A., Torp R., Lin C.Y., Pineda E.A., Lynch G., and Gall C.M. Integrin signaling cascades are operational in adult hippocampal synapses and modulate NMDA receptor physiology. J. Neurochem. 93 (2005) 834-849
8. Bilousova T.V., Rusakov D.A., Ethell D.W., and Ethell I.W. Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J. Neurochem. 97 (2006) 44-56
9. Boire A., Covic L., Agarwal A., Jacques S., Sherifi S., and Kuliopulos A. PAR1 is a matrix metalloproteinase-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120 (2005) 303-313
10. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477 (2000) 267-283
11. Brinckerhoff C.E., and Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev., Mol. Cell Biol. 31 (2002) 207-214
12. Bruno M.A., and Cuello A.C. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6735-6740
13. Cawston T.E., and Wilson A.J. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract. Res. Clin. Rheumatol. 20 (2006) 983-1002
14. Chang C., and Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11 (2001) S37-S43
15. Chen W.T., and Wang J.W. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann. N.Y. Acad. Sci. 878 (1999) 361-371
16. Conant K., St Hillaire C., Nagase H., Visse R., Gary D., Haughey N., Anderson C., Turchan J., and Nath A. Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt. J. Biol. Chem. 279 (2004) 8056-8062
17. Crocker S.J., Whitmire J.K., Frausto R.F., Chertboonmuang P., Soloway P.D., Whitton L.J., and Campbell I.L. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am. J. Pathol. 169 (2006) 2104-2116
18. Cross A.K., and Woodroofe M.N. Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 28 (1999) 183-189
19. Cunningham L.A., Wetzel M., and Rosenberg G.A. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50 (2005) 329-339
20. Cuzner M.L., Gveric D., Strand C., Loughlin A.J., Paemen L., Opdenakker G., and Newcombe J. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55 (1996) 1194-1204
21. D'Ercole A.J., Ye P., Calikoglu A.S., and Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol. 13 (1996) 227-255
22. Dityatev A., and Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat. Rev., Neurosci. 4 (2003) 456-468
23. Esper R.M., Pankonin M.S., and Loeb J.A. Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. Brains Res. Rev. 51 (2005) 161-175
24. Ethell D.W., and Buhler L.A. Fas ligand-mediated apoptosis in degenerative disorders of the brain. J. Clin. Immunol. 23 (2003) 439-446
25. Fager N., and Jaworski D.M. Differential spatial distribution and temporal regulation of tissue inhibitor of metalloproteinase mRNA expression during rat central nervous system development. Mech. Dev. 98 (2000) 105-109
26. Ferguson T.A., and Muir D. MMP-2 and MMP-9 increase the neurite-promoting potential of Schwann cell basal laminae and are upregulated in degenerated nerve. Mol. Cell. Neurosci. 16 (2000) 157-167
27. Flannery C.R. MMPs and ADAMTSs: functional studies. Front. Biosci. 11 (2006) 544-569
28. Fowlkes J.L., Serra D.M., Bunn R.C., Thrailkill K.M., Enghild J.J., and Nagase H. Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF-binding protein-3 complexes. Endocrinology 145 (2004) 620-626
29. Frolichsthal-Schoeller P., Vescovi A.L., Krekoski C.A., Murphy G., Edwards D.R., and Forsyth P. Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells. NeuroReport 10 (1999) 345-351
30. Galko M.J., and Tessier-Levigne M. Function of an axonal chemoattractant modulated by metalloproteinase activity. Science 289 (2000) 1365-1367
31. Gasche Y., Soccal P.M., Kanemitsu M., and Copin J.-C. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front. Biosci. 11 (2006) 1289-1301
32. Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W.G., and Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277 (1997) 225-228
33. Gottschall P.E., and Deb S. Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons. Neuroimmunomodulation 3 (1996) 69-75
34. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington C., and Lipton S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297 (2002) 1186-1190
35. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., and Lipton S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25 (2005) 6401-6408
36. Gursoy-Ozdemir Y., Matsuoka J., Bolay N., Bermpohl H., Jin D., Wang H., Rosenberg X., Lo G.A., and Moskowitz E.H. Cortical spreading depression activates and upregulates MMP-9. J. Clin. Invest. 113 (2004) 1447-1455
37. Harkness K.A., Adamson P., Sussman J.D., Davies-Jones G.A., Greenwood J., and Woodroofe M.N. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123 (2000) 698-709
38. Harrington A.W., Leiner B., Blechsmitt C., Arevalo J.C., Lee R., Morl K., Meyer M., Hempstead B.L., Yoon S.O., and Giehl K.M. Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6226-6230
39. Heine W., Conant K., Griffin J.W., and Hoke A. Transplanted neural stem cells promote axonal regeneration through chronically denervated peripheral nerves. Exp. Neurol. 189 (2004) 231-240
40. Hsu J.Y., McKeon R., Goussev S., Werb Z., Lee J.U., Trivedi A., and Noble-Haeusslein L.J. Matrix metalloproteinase 2 facilitates wound healing events that promote functional recovery after spinal cord injury. J. Neurosci. 26 (2006) 9841-9850
41. Hummel V., Kallmann B.A., Wagner S., Fuller T., Bayas A., Tonn J.C., Benveniste E.N., Toyka K.V., and Rieckmann P. Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J. Neuropathol. Exp. Neurol. 60 (2001) 320-327
42. Ii M., Yamamoto H., Adachi Y., Maruyama Y., and Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp. Biol. Med. 231 (2006) 20-27
43. Ivaska J., Nissinen L., Immonen N., Eriksson J.E., Kahari V.M., and Heino J. Integrin alpha 2 beta 1 promotes activation of protein phosphate 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta. Mol. Biol. 22 (2002) 1352-1359
44. Jiang Y.F., Goldberg I.D., and Shi Y.E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21 (2002) 2245-2252
45. Jourquin J., Tremblay E., Bernard A., Charton G., Chaillan F.A., Marchetti E., Roman F.S., Soloway P.D., Dive V., Yiotakis A., Khrestchatisky M., and Rivera S. Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur. J. Neurosci. 22 (2005) 2569-2578
46. Jung K.K., Liu X.W., Chirco R., Fridman R., and Kim H.R. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 25 (2006) 3934-3942
47. Kim H.J., Fillmore H.L., Reeves T.M., and Phillips L.L. Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis. Exp. Neurol. 192 (2005) 60-72
48. Larsen P.H., and Yong V.W. The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation. J. Neurosci. 24 (2004) 7597-7603
49. Larsen P.H., DaSilva A.G., Conant K., and Yong V.W. Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice. J. Neurosci. 26 (2006) 2207-2214
50. Lee R., Kermani P., Teng K.K., and Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 294 (2001) 1945-1948
51. Lee Y.M., Bae M.H., Lee O.H., Moon E.J., Moon C.K., Kim W.H., and Kim K.W. Synergistic induction of in vivo angiogenesis by the combination of insulin-like growth factor-II and epidermal growth factor. Oncol. Rep. 12 (2004) 843-848
52. Lee S.R., Kim H.Y., Rogowska J., Zhao B.Q., Bhide P., Parent J.M., and Lo E.H. Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J. Neurosci. 26 (2006) 3491-3495
53. Lemaitre V., and D'Armiento J. Matrix metalloproteinases in development and disease. Birth Defects Res. C Embryo Today 78 (2006) 1-10
54. Lorenzl S., Albers D.S., Chirichigno J.W., Augood S.J., and Beal M.F. Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy. J. Neurol. Sci. 218 (2004) 39-45
55. Luo J. The role of matrix metalloproteinases in the morphogenesis of the cerebellum. Cerebellum 4 (2005) 239-245
56. Maeda A., and Sobel R.A. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55 (1996) 300-309
57. Machida C.M., Rodland K.D., Matrisian L., Magun B.E., and Ciment G. NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells. Neuron 2 (1989) 1587-1596
58. Manabe S., Gu Z., and Lipton S.A. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4747-4753
59. Manello F., Luchette F., Falcieri E., and Papa S. Multiple roles of matrix metalloproteinases during apoptosis. Apoptosis 10 (2005) 19-24
60. Manna P.P., Dimitry J., Oldenborg P.A., and Frazier W.A. CD47 augments Fas/CD-95-mediated apoptosis. J. Biol. Chem. 280 (2005) 29637-29644
61. Meighan S.E., Meighan P.C., Choudhury P., Davis C.J., Olson M.L., Zornes P.A., Wright J.W., and Harding J.W. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J. Neurochem. 96 (2006) 1227-1241
62. Messent A.J., Tuckwell D.S., Knauper V., Humphries M.J., Murphy G., and Gavrilovic J. Effects of collagenase-cleavage of type I collagen on α2β1 integrin-mediated cell adhesion. J. Cell Sci. 111 (1998) 1127-1135
63. Mitsiades N., Yu W., Poulaki V., Tsokos M., and Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumour cells from chemotherapeutic drug cytotoxicity. Cancer Res. 61 (2001) 577-581
64. Monea S., Jordan B.A., Srivastava S., DeSouza S., and Ziff E.B. Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins. J. Neurosci. 26 (2006) 2300-2312
65. Muir D. Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin. Exp. Metastasis. 13 (1995) 303-314
66. Muir E.M., Adcock K.H., Morgenstern D.A., Clayton R., von Stillfried N., Rhodes K., Ellis C., Fawcett J.W., and Rogers J.H. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res. Mol. Brain Res. 100 (2002) 103-117
67. Munshi H.G., and Stack M.S. Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Res. 25 (2006) 45-56
68. Nagase H., Visse R., and Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69 (2006) 562-573
69. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R.M., Silva A.J., Kaczmarek L., and Huntley G.W. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J. Neurosci. 26 (2006) 1923-1934
70. Nakamura M., Miyamoto S., Maeda H., Ishii G., Hasebe T., Chiba T., Asaka M., and Ochiai A. Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. Biochem. Biophys. Res. Commun. 333 (2005) 1011-1016
71. Nordstrom L.A., Lochner J., Yeung W., and Ciment G. The metalloproteinase stomelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae. Mol. Cell. Neurosci. 6 (1995) 56-68
72. Ogier C., Bernard A., Chollet A.M., Le Diquardher T., Hanessian S., Charton G., Khrestchatisky M., and Rivera S. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 54 (2006) 272-284
73. Oh L.Y., Larsen P.H., Yong V.W., Krekoski C.A., Edwards D.R., Donovan F., and Werb Z. Gelatinase B/matrix metalloproteinase-9 is required for oligodendroglial process extension in vivo and in vitro. J. Neurosci. 19 (1999) 8464-8475
74. Okamoto M., Wang X., and Baba M. HIV-1 infected macrophages induce astrogliosis by SDF-1alpha and matrix metalloproteinases. Biochem. Biophys. Res. Commun. 336 (2005) 1214-1220
75. Olle E.W., Ren X., McClintock S.D., Warner R.L., Deogracias M.P., Johnson K.J., and Colletti L.M. Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice. Hepatology 44 (2006) 540-549
76. Orbe J., Montero I., Rodriguez J.A., Beloqui O., Roncal C., and Paramo J.A. Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis. J. Thromb. Haemost. 5 (2007) 91-97
77. Ossovskaya V.S., and Bunnett N.W. Protease-activated receptors: contribution to physiology and disease. Physiol. Rev. 84 (2004) 579-621
78. Overall C.M., and Dean R.A. Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 25 (2006) 69-75
79. Pagenstecher A., Stalder A.K., Kincaid C.L., Shapiro S.D., and Campbell I.L. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 152 (1998) 729-741
80. Pastrana E., Moreno-Flores M.T., Gurzov E.N., Avila J., Wandosell F., and Diaz-Nido J. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. J. Neurosci. 26 (2006) 5347-5359
81. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1104-1117
82. Pérez-Martínez L., and Jaworski D.M. Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J. Neurosci. 25 (2005) 4917-4929
83. Powell W.C., Fingleton B., Wilson C.L., Boothby M., and Matrisian L.M. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9 (1999) 1441-1447
84. Puente X.S., Sánchez L.M., Overall C.M., and López-Otín C. Human and mouse proteases: a comparative genomic approach. Nat. Rev., Genet. 4 (2003) 544-558
85. Reddig P.J., and Juliano R.L. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 24 (2005) 425-439
86. Reeves T.M., Prins M.L., Zhu J., Povlishock J.T., and Phillips L.L. Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J. Neurosci. 23 (2003) 10182-10189
87. Rivera S., Tremblay E., Timsit S., Canals O., Ben-Ari Y., and Khrestchatisky M. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J. Neurosci. 17 (1997) 4223-4235
88. Santiskulvong C., and Rozenqurt E. Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells. Exp. Cell Res. 290 (2003) 437-446
89. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., and Seiki M.A. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 (1994) 61-65
90. Serandour A.L., Loyer P., Garnier D., Courseland B., Theret N., Glaise D., Guguen-Guillouzo C., and Corlu A. TNFalpha-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology 41 (2005) 478-486
91. Sheffield J.B., Krasnopolsky V., and Dehlinger E. Inhibition of retinal growth cone activity by specific metalloproteinase inhibitors in vitro. Dev. Dyn. 200 (1994) 79-88
92. Shiosaka S. Serine proteases regulating synaptic plasticity. Anat. Ser. Int. Inst. 79 (2004) 137-144
93. Shubayev V.I., and Myers R.R. Matrix metalloproteinase-9 promotes nerve growth factor-induced neurite elongation but not new sprout formation in vitro. J. Neurosci. Res. 77 (2004) 229-239
94. Si-Tayeb K., Monvoisin A., Mazzocco C., Lepreux S., Decossa M., Cubel G., Taras D., Blanc J.F., Robinson D.R., and Rosenbaum J. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am. J. Pathol. 169 (2006) 1390-1401
95. Steinhoff M., Buddenkotte J., Shpacovitch V., Rattenholl A., Moormann C., Vergnolle N., Luger T.A., and Hollenberg M.D. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr. Rev. 26 (2005) 1-43
96. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behaviour. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
97. Strazielle N., Khuth S.T., Murat A., Chalon A., Giraudon P., Belin M.F., and Ghersi-Egea J.F. Pro-inflammatory cytokines modulate matrix metalloproteinase secretion and organic anion transport at the blood-cerebrospinal fluid barrier. J. Neuropathol. Exp. Neurol. 62 (2003) 1254-1264
98. Streuli S. Extracellular matrix remodeling and cellular differentiation. Curr. Opin. Cell Biol. 11 (1999) 634-640
99. Suzuki M., Raab R.G., Moses M.A., Fernandez C.A., and Klagsbrun M. Matrix metalloproteinase 3 releases active heparin binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272 (1997) 31730-31737
100. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., and Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 22 (2002) 920-930
101. Takenaga K., and Kozlova E.N. Role of intracellular S100A4 for migration of rat astrocytes. Glia 53 (2006) 313-321
102. Tsukatani T., Fillmore H.L., Hamilton H.R., Holbrook E.H., Costanzo R.M., Oba T., Ukeda H., Matsumoto K., Miwa T., Furukawa M., Ishimaru T., Hatanaka S., Yata T., Horikawa I., Nishimura T., Kanehira E., Ge Y., DiNardo L.J., Reiter E.R., Yamamoto M., Katayama Y., Moriya M., Tanaka S., Okoyama S., Moriizumi T., Sakashita H., Awaji T., and Shigemitsu K. Matrix metalloproteinase expression in the olfactory epithelium. NeuroReport 14 (2003) 1135-1140
103. Turgeon V.L., Milligan C.E., and Houenou L.J. Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J. Neuropathol. Exp. Neurol. 58 (1999) 400-504
104. Uhm J.H., Dooley N.P., Oh L.Y., and Yong V.W. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22 (1998) 53-63
105. Vaillant C., Didier-Bazes M., Hutter A., Belin M.F., and Thomasset N. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J. Neurosci. 19 (1999) 4994-5004
106. Vaillant C., Meissirel C., Mutin M., Belin M.F., Lund L.R., and Thomasset N. MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Mol. Cell. Neurosci. 24 (2003) 395-408
107. VanSaun M.N., and Matrisian L.M. Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Res. C Embryo Today 78 (2006) 69-79
108. VanSaun M., Herrerra A.A., and Werle M.J. Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice. J. Neurocytol. 32 (2003) 1129-1142
109. Vargo-Gogola T., Crawford H.C., Fingleton B., and Matrisian L.M. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch. Biochem. Biophys. 408 (2002) 155-161
110. Vecil G.G., Larsen P.H., Corley S.M., Herx L.M., Besson A., Goodyer C.G., and Yong V.W. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J. Neurosci. Res. 61 (2000) 212-224
111. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function and biochemistry. Circ. Res. 92 (2003) 827-839
112. Williams K.C., Ulvestad E., and Hickey W.F. Immunology of multiple sclerosis. Clin. Neurosci. 2 (1994) 229-245
113. Wright J.W., Masino A.J., Reichert J.R., Turner G.D., Meighan S.E., Meighan P.C., and Harding J.W. Ethanol-induced impairment of spatial memory and brain matrix metalloproteinases. Brain Res. 963 (2003) 252-261
114. Yong V.W., Power C., Forsyth P., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev., Neurosci. 2 (2001) 502-511
115. Zhang J.W., Deb S., and Gottschall P.E. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur. J. Neurosci. 10 (1998) 3358-3368
116. Zhang X., Cheng M., and Chintala S.K. Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2374-2383
117. Zhao W.O., Li H., Yamashita K., Guo X.K., Hoshino T., Yoshida S., Shinya T., and Hayakawa T. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J. Cell Sci. 111 (1998) 1147-1153
118. Zhao B.Q., Wang S., Kim H.Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., and Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12 (2006) 441-445
119. Zuo J., Ferguson T.A., Hernandez Y.J., Stetler-Stevenson W.G., and Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 18 (1998) 5203-5211